ITMCTR2200006493
Not yet recruiting
未知
A multicenter, prospective, open, cohort study on the efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of chronic kidney disease stage 3-4
the First Affiliated Hospital of Anhui University of Chinese Medicine0 sitesTBD
Conditionschronic kidney disease stage 3-4
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic kidney disease stage 3-4
- Sponsor
- the First Affiliated Hospital of Anhui University of Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Age 18 \~ 70 years old, ? meet the diagnostic criteria of CKD stage 3\-4; ? Blood pressure \< 140/90mmhg, blood potassium \< 5\.5mmol/l, hemoglobin \= 80g/l, infection was controlled, and the condition was stable for more than 2 weeks; ? Those who did not use Chinese patent medicine for CKD within 2 weeks before enrollment, or who had used Chinese patent medicine but had a 2\-week washout period; ? Sign informed consent.
Exclusion Criteria
- •? Pregnant or lactating patients ? unable to cooperate, such as psychotic patients ? complicated with active malignant tumors, infectious diseases, liver cirrhosis decompensation, hematopoietic system and other serious primary diseases; ? There is acute urinary tract obstructive disease, which needs surgical treatment; ? Severe arrhythmia, heart failure, NYHA grade III or above, or myocardial infarction or cerebrovascular events within 3 months before enrollment; ? Using corticosteroids, non steroidal anti\-inflammatory drugs or immunosuppressants; ? Accord with the clinical or pathological diagnosis of diabetes kidney disease; ? Patients are unwilling to participate and refuse to sign informed consent; ? Patients who are participating in other clinical trials
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Polatuzumab vedotin plus R-CHP therapy in patients with previously untreated diffuse large B-cell lymphomaDiffuse large B-cell lymphomDLBCLDLBCJPRN-jRCT1071220082Kato Koji500
Recruiting
Not Applicable
Study to check safety and effectiveness of cilnidipine, metoprolol succinate and chlorthalidone in Indian hypertensive patients.Health Condition 1: I10- Essential (primary) hypertensionCTRI/2019/01/017089Aprica Healthcare Pvt Ltd
Completed
Not Applicable
A multicenter, prospective, observational study for the association serum pancreatic enzyme level and CT image findings in post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024814Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Completed
Not Applicable
A multicenter, prospective, observational study for the incidence and high risk factor of post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024813Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Recruiting
Not Applicable
A multicenter, prospective, observational study for the control of delayed chemotherapy-induced nausea and vomiting for upper gastrointestinal cancerJPRN-UMIN000052322agoya University135